CELL AND VIRAL VECTOR LABORATORY SHARED RESOURCE Project Summary The mission of the Cell and Viral Vector Laboratory (CVVL) Shared Resource is to serve the scientific needs of Wake Forest Baptist Comprehensive Cancer Center (WFBCCC) researchers by offering customized assistance for specialized cell culture and viral vector production; and by providing quality control for each research project. The use of primary and established cultures from cancerous and non-cancerous origins is essential for cancer research and requires careful quality control to maintain appropriate phenotype and functions. In addition, the use of various viral vectors (including lentivirus, retrovirus and adenovirus) has become a critical experimental technique for cancer research to effectively manipulate gene expression and to create desired mutations in particular genes. The CVVL also serves as a central site for purchasing and distributing specific culture media/reagents, molecular biology kits, and standard laboratory supplies in a cost- effective manner for WFBCCC members.
The Specific Aims of CVVL are to 1) provide specialized cell culture services that support WFBCCC members' research needs, in an efficient and cost-effective manner; 2) maintain a cell repository of commonly used cell lines for WFBCCC member use; 3) provide WFBCCC members access to specialized equipment not readily available or not cost-effective for individual researchers; and 4) serve as a distribution center for critical cell culture and molecular biology reagents. The CVVL is extensively utilized by more than 139 Principal Investigators (both WFBCCC members and non-members) annually; 63% of services support the research of WFBCCC members. Services are provided to investigators on all institutional campuses at substantial cost savings with work conducted under stringent standard operating procedures. The expertise of the CVVL Director, Purnima Dubey, Ph.D., and the efforts of two technicians (1.5 FTE) provide high-quality cell culture and viral vector production services to researchers at WFBCCC. In the future, the CVVL plans to extend the viral production service by expanding its cutting-edge viral vector systems.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA012197-43
Application #
9422679
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
43
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Wake Forest University Health Sciences
Department
Type
DUNS #
937727907
City
Winston-Salem
State
NC
Country
United States
Zip Code
27157
Park, Sun H; Keller, Evan T; Shiozawa, Yusuke (2018) Bone Marrow Microenvironment as a Regulator and Therapeutic Target for Prostate Cancer Bone Metastasis. Calcif Tissue Int 102:152-162
Haas, Karen M; Johnson, Kristen L; Phipps, James P et al. (2018) CD22 Promotes B-1b Cell Responses to T Cell-Independent Type 2 Antigens. J Immunol 200:1671-1681
Suo, Xubin; Eldridge, Brittany N; Zhang, Han et al. (2018) P-Glycoprotein-Targeted Photothermal Therapy of Drug-Resistant Cancer Cells Using Antibody-Conjugated Carbon Nanotubes. ACS Appl Mater Interfaces 10:33464-33473
Widner, D Brooke; Park, Sun H; Eber, Matthew R et al. (2018) Interactions Between Disseminated Tumor Cells and Bone Marrow Stromal Cells Regulate Tumor Dormancy. Curr Osteoporos Rep 16:596-602
Liu, Liang; Ruiz, Jimmy; O'Neill, Stacey S et al. (2018) Favorable outcome of patients with lung adenocarcinoma harboring POLE mutations and expressing high PD-L1. Mol Cancer 17:81
Sirkisoon, Sherona R; Carpenter, Richard L; Rimkus, Tadas et al. (2018) Interaction between STAT3 and GLI1/tGLI1 oncogenic transcription factors promotes the aggressiveness of triple-negative breast cancers and HER2-enriched breast cancer. Oncogene 37:2502-2514
Goyal, Amrita; Carter, Joi B; Pashtan, Itai et al. (2018) Very low-dose versus standard dose radiation therapy for indolent primary cutaneous B-cell lymphomas: A retrospective study. J Am Acad Dermatol 78:408-410
Su, Weijun; Hong, Lixin; Xu, Xin et al. (2018) miR-30 disrupts senescence and promotes cancer by targeting both p16INK4A and DNA damage pathways. Oncogene 37:5618-5632
Miller Jr, David P; Denizard-Thompson, Nancy; Weaver, Kathryn E et al. (2018) Effect of a Digital Health Intervention on Receipt of Colorectal Cancer Screening in Vulnerable Patients: A Randomized Controlled Trial. Ann Intern Med 168:550-557
Bonin, Keith; Smelser, Amanda; Moreno, Naike Salvador et al. (2018) Structured illumination to spatially map chromatin motions. J Biomed Opt 23:1-8

Showing the most recent 10 out of 548 publications